1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

Upcoming FDA Reorg Overhauls Office of Regulatory Affairs

 
• By Elizabeth Orr

The US FDA hopes to make major changes in 2024, including an inspections-focused replacement for the Office of Regulatory Affairs, a new Office of the Chief Medical Officer, and moving labs currently within ORA to the Office of the Chief Scientist.

FDAEntrance_1200x675

Prepare to say goodbye to the Office of Regulatory Affairs and hello to the Office of Inspections and Investigations in 2024.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation